Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical

August 27, 2026
Jetstream Venture Fund has added ImageAiD and Moonrise Medical to its healthtech portfolio. Both companies are developing AI tools for vascular diagnostics and Peripheral Artery Disease screening.

Jetstream Venture Fund announced in a press release new portfolio investments in ImageAiD and Moonrise Medical, two healthtech companies building AI vascular diagnostic tools for Peripheral Artery Disease.

ImageAiD combines Mayo Clinic validated research, a handheld Doppler device, and predictive AI software to help detect Peripheral Artery Disease before physical symptoms appear in primary care settings.

Moonrise Medical automates Doppler ultrasound assessments and Pedal Acceleration Time calculations. The company says its platform is designed to help clinicians evaluate vascular health without specialized sonographers.

Jetstream said Peripheral Artery Disease affects more than 200 million people globally and 12 million people in the United States. The fund did not disclose the size of the investments.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

08/27
SK Telecom to Create SK Horizon for AI Data Centers
08/27
ProFound Gets Gates Foundation Investment for AI Maternal Health Research
08/27
Kasm and Intel Expand Private AI Workspaces for Xeon 6
08/27
Nasuni Acquires DryvIQ to Add Unstructured Data Governance for AI
08/27
fileAI Gets Investment From SMBC Asia Rising Fund and Singtel Innov8

More from: Life Sciences

08/27
Tianjin University and United Imaging Unveil MRI Based BCI System
08/27
ProFound Gets Gates Foundation Investment for AI Maternal Health Research
08/27
Predoc Launches Curated Data Layer for Medical Records
08/27
UT Medical and TransformativeMed Build Agentic AI Discharge Planning Tool
08/27
BioVid Launches Tumor Worlds for Oncology Market Intelligence

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like